+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Do new cancer drugs offer good value for money? the perspective of oncologists, payers, patients, and general population



Do new cancer drugs offer good value for money? the perspective of oncologists, payers, patients, and general population



Value in Health 17(7): A327




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057647889

Download citation: RISBibTeXText

PMID: 27200550

DOI: 10.1016/j.jval.2014.08.592


Related references

Do new Cancer drugs offer good value for Money? the perspective of oncologists, payers, patients, and general Population. Clinical Therapeutics 37(8): E18-E19, 2015

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population. Patient Preference and Adherence 10: 1-7, 2016

Do oncologists believe new cancer drugs offer good value?. Journal of Clinical Oncology 23(16_Suppl): 6011-6011, 2016

Do oncologists believe new cancer drugs offer good value?. Oncologist 11(2): 90-95, 2006

The importance of good death components among cancer patients, the general population, oncologists, and oncology nurses in Japan: patients prefer "fighting against cancer". Supportive Care in Cancer 23(1): 103-110, 2015

In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems. Thrombosis Research 171: 97, 2018

Hospitals with TQM offer good value to payers. Health Progress 73(5): 17-9 24, 1992

Does good medication adherence really save payers money?. Medical Care 53(6): 517-523, 2015

What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)?. Radiotherapy and Oncology 48(3): 233-248, 1998

Good training, systems and funding, not good luck: what hematologists and oncologists believe would make it easier for them to refer their cancer patients to psychosocial care. Translational Behavioral Medicine 9(1): 139-146, 2019

A decade of new cancer drugs: good value for money. Pharmacoeconomics & Outcomes News 680(1): 10-10, 2013

Despite high costs, specialty drugs may offer value for money comparable to that of traditional drugs. Health Affairs 33(10): 1751-1760, 2014

Do Specialty Drugs Offer Greater Value for Money Than Traditional Drugs?. Value in Health 17(7): A419-A420, 2014

The cancer drugs fund in england - undermining nice or efficient and good value for money?. Value in Health 18(7): A335, 2015

Evaluating Adverse Events Costs in Cancer Patients in Lebanon From Two Payers Perspective. Value in Health 20(9): A432-A433, 2017